← Open Payments lookup

QUAYCIAN STEWART-KODADAR: Open Payments

NPI 1265139828 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,160 in 176 payments from 19 companies in 2025. Trend: 2023 $2,161 · 2024 $2,521 · 2025 $3,160

Food & beverage: $3,160
CompanyPaymentsAmount
ABBVIE INC.34$582
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$320
Otsuka America Pharmaceutical, Inc.17$300
Neurocrine BioSciences, Inc.12$226
Collegium Pharmaceutical, Inc.14$217
Vanda Pharmaceuticals Inc.9$214
Alkermes, Inc.11$207
Axsome Therapeutics, Inc.7$180
E.R. Squibb & Sons, L.L.C.8$175
Corium, LLC8$170

Products named: VRAYLAR, CAPLYTA, INGREZZA, Jornay PM, Auvelity, COBENFY, Azstarys, ABILIFY ASIMTUFII.

Industry payments across FL — which companies pay providers there.